Resmed Inc. Earnings

Resmed Inc.’s revenue jumped 10.2% since last year same period to $1347.99Mn in the Q2 2025. On a quarterly growth basis, Resmed Inc. has generated 4.36% jump in its revenue since last 3-months.

Resmed Inc.’s net profit jumped 29.93% since last year same period to $379.71Mn in the Q2 2025. On a quarterly growth basis, Resmed Inc. has generated 4.02% jump in its net profits since last 3-months.

Resmed Inc.’s net profit margin jumped 17.9% since last year same period to 28.17% in the Q2 2025. On a quarterly growth basis, Resmed Inc. has generated -0.32% fall in its net profit margins since last 3-months.

Resmed Inc.’s price-to-earnings ratio after this Q2 2025 earnings stands at 30.02.

Resmed Inc.’s earning per share (EPS) estimates for the current quarter stand at 2.47 - a -0.4% fall from last quarter’s estimates.

Resmed Inc.’s earning per share (EPS) estimates for the current year stand at 2.47.

Resmed Inc.’s earning per share (EPS) jumped 22.6% since last year same period to 2.55 in the Q2 2025. This indicates that the Resmed Inc. has generated 22.6% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Resmed Inc.’s return on assets (ROA) stands at 0.14.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Resmed Inc.’s return on equity (ROE) stands at 0.26.

Resmed Inc. declared 0.53 dividend per share during the earnings announcement for Q2 2025.